Dr George Laking

MD, PhD, FRACP

Biography

Kōrihi te manu, tākiri te ata, ka ao, ka ea, ka awatea.

 

George grew up in Wellington and studied medicine in Dunedin and Wellington.  He completed his postgraduate work in Britain where he wrote his MD on tumour perfusion and his PhD on the economics of diagnosis.  Since 2007 he has worked as a Medical Oncologist in Auckland, with current focus areas of gastrointestinal cancer, sarcoma, and adolescent and young adult oncology.  Alongside his hospital work, George is active in Policy and Advocacy at the Royal Australasian College of Physicians (topics including climate change, medical assistance in dying, electronic nicotine delivery systems, and Indigenous health.  At the University of Auckland George is involved in clinical teaching, and collaborates in research with Prof Mark McKeage (Clinical Pharmacology) and Prof Chris Bullen (National Institute for Health Innovation).  He is a former member of PHARMAC's Pharmacology and Therapeutics Advisory Committee (PTAC).

George's iwi affiliation is Te Whakatōhea, he is involved in Māori Health as a past Chair of Te ORA (the Māori Medical Practitioners' Association), as current Chair of the Māori Health Committee of the RACP, and a board member of Hei Ahuru Mowai Maori Cancer Leadership Aotearoa.

Research | Current

  • Nicotine replacement
  • Māori health
  • AYA oncology

Teaching | Current

Clinical tutoring undergraduate medicine

Areas of expertise

  • Sarcoma
  • lung cancer,
  • Electronic Cigarettes
  • Tobacco control
  • Māori health
  • Medicines policy
  • Health economics
  • AYA oncology

Committees/Professional groups/Services

Chair of the Māori Health Committee of the RACP, Member of the Specialist Council of the NZMA

Selected publications and creative works (Research Outputs)

  • Laking, G., Evans, J., Metcalfe, S., & Strother, R. M. (2018). Response to Cameron et al "Mind the graph" Semin Oncol. 2018. Seminars in oncology, 45 (5-6), 318-319. 10.1053/j.seminoncol.2018.08.003
  • Burns, K. E., Lo, W. Y., Findlay, M. P., Sharples, K., Laking, G., & Helsby, N. A. (2016). High CYP2C19 phenotypic variability in gastrointestinal cancer patients. Cancer Chemotherapy and Pharmacology, 77 (1), 195-204. 10.1007/s00280-015-2923-4
    URL: http://hdl.handle.net/2292/41465
    Other University of Auckland co-authors: Katie Burns, Michael Findlay, Nuala Helsby
  • Robinson, J., Boyd, M., O'Callaghan A, Laking, G., Frey, R., Raphael, D., ... Gott, M. (2015). The extent and cost of potentially avoidable admissions in hospital inpatients with palliative care needs: A cross-sectional study. BMJ Supportive and Palliative Care, 5 (3), 266-272. 10.1136/bmjspcare-2014-000724
    URL: http://hdl.handle.net/2292/27528
    Other University of Auckland co-authors: Merryn Gott, Deborah Raphael, Jacqualine Robinson, Rosemary Frey, Michal Boyd, Anne O'Callaghan
  • Monasterio, E., Laking, G., & Pattemore, P. (2015). The perils of the TPP. Nursing New Zealand (Wellington, N.Z. : 1995), 21 (7)
  • Beatty, P. A., & Laking, G. R. (2015). Oncology pharmaceutical funding in New Zealand: a different approach and a proposal. Journal of oncology practice, 11 (3), 249-251. 10.1200/jop.2014.000083
  • Monasterio, E., Laking, G., & Pattemore, P. (2015). The perils of the TPP. Kai Tiaki Nursing New Zealand, 21 (7)
  • Laking, G. (2015). Balancing profits with public good. Kai Tiaki Nursing New Zealand, 21 (4)
  • Lawrenson, R., Lao, C., Obertová Z, Brown, C., Holmes, M., Tyrie, L., ... Laking, G. (2015). Management and characteristics of patients with metastatic prostate cancer in a cohort of New Zealand men. Oncology (Switzerland), 88 (3), 157-163. 10.1159/000368319

Contact details

Primary office location

M&HS BUILDING 501 - Bldg 501
Level SB, Room SB03
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand